MRI for breast cancer screening, diagnosis, and treatment

M Morrow, J Waters, E Morris - The Lancet, 2011 - thelancet.com
MRI is used widely both for screening women who are at increased risk of breast cancer and
for treatment selection. Prospective studies confirm that MRI screening of women with known …

[HTML][HTML] Imaging and cancer: a review

L Fass - Molecular oncology, 2008 - Elsevier
Multiple biomedical imaging techniques are used in all phases of cancer management.
Imaging forms an essential part of cancer clinical protocols and is able to furnish …

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group

F Sardanelli, C Boetes, B Borisch, T Decker… - European journal of …, 2010 - Elsevier
The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA
organised a workshop in Milan on 20–21st October 2008 to evaluate the evidence currently …

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy

ML Marinovich, N Houssami, P Macaskill… - Journal of the …, 2013 - academic.oup.com
Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

[HTML][HTML] Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions

RG Pleijhuis, M Graafland, J de Vries, J Bart… - Annals of surgical …, 2009 - Springer
Inadequate surgical margins represent a high risk for adverse clinical outcome in breast-
conserving therapy (BCT) for early-stage breast cancer. The majority of studies report …

[HTML][HTML] The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant …

MBI Lobbes, R Prevos, M Smidt, VCG Tjan-Heijnen… - Insights into …, 2013 - Springer
Objectives This systematic review aimed to assess the role of magnetic resonance imaging
(MRI) in evaluating residual disease extent and the ability to detect pathologic complete …

Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational …

JF De Los Santos, A Cantor, KD Amos, A Forero… - Cancer, 2013 - Wiley Online Library
BACKGROUND: Increased pathologic complete response (pCR) rates observed with
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …

[HTML][HTML] Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

RFD Van la Parra, HM Kuerer - Breast Cancer Research, 2016 - Springer
With improvements in chemotherapy regimens, targeted therapies, and our fundamental
understanding of the relationship of tumor subtype and pathologic complete response …

[HTML][HTML] Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta …

YL Gu, SM Pan, J Ren, ZX Yang, GQ Jiang - Clinical Breast Cancer, 2017 - Elsevier
Pathologic complete remission after neoadjuvant chemotherapy has a role in guiding the
management of breast cancer. The present meta-analysis examined the accuracy of contrast …

Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer …

R Croshaw, H Shapiro-Wright, E Svensson… - Annals of surgical …, 2011 - Springer
Background To determine the accuracy, positive predictive value (PPV), and negative
predictive value (NPV) of clinical examination and breast imaging techniques in determining …